🇪🇺 Oral P2Y12 receptor blocker in European Union

Oral P2Y12 receptor blocker (Oral P2Y12 receptor blocker) regulatory status in European Union.

Marketing authorisation

EMA

  • Status: approved

Oral P2Y12 receptor blocker in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Cardiovascular approved in European Union

Frequently asked questions

Is Oral P2Y12 receptor blocker approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Oral P2Y12 receptor blocker in European Union?

Italian Society of Invasive Cardiology is the originator. The local marketing authorisation holder may differ — check the official source linked above.